Categories AlphaGraphs, Earnings, Industrials
ANGO Earnings: A snapshot of AngioDynamics’ Q1 2025 results
AngioDynamics Inc. (NASDAQ: ANGO) Thursday reported a net loss for the first quarter of 2025. The medical device company’s revenues decreased by double-digit during the three months.
Net loss, excluding special items, was $0.11 per share in the August quarter, compared to a loss of $0.12 per share in the corresponding period of 2024. On an unadjusted basis, net loss narrowed to $12.8 million or $0.31 per share in Q1 from $45.9 million or $1.15 per share in the prior-year quarter.
Revenues, on a reported basis, decreased 14% year-over-year to $67.5 million in the first quarter. The company expects fiscal 2025 sales to be in the range of $282 million to $288 million.
Commenting on the results, AngioDynamics’ CEO Jim Clemmer said, “We expect to continue to deliver strong revenue growth within our Med Tech business as we execute on key commercial initiatives. We remain focused on executing our growth strategy and advancing our innovative product portfolio.”
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
